• No results found

ENTERPRISE AND KNOWLEDGE TRANSFER. Research Commercialisation and Technology Transfer

N/A
N/A
Protected

Academic year: 2021

Share "ENTERPRISE AND KNOWLEDGE TRANSFER. Research Commercialisation and Technology Transfer"

Copied!
16
0
0

Loading.... (view fulltext now)

Full text

(1)

Research Commercialisation and Technology Transfer

ENTERPRISE AND KNOWLEDGE TRANSFER

(2)

Course Summary 05 What you will learn 06 on the course?

The learning journey 08

Learning breakdown 10

Meet your tutors 11

Technical requirements 14

Course certification 14

(3)

03

ENTERPRISE & KNOWLEDGE TRANSFER

We are delighted to offer this exciting programme of short online courses for

professionals, giving you the opportunity to harness the latest research, innovation and thinking that the University of Cambridge has to offer.

Cambridge Advance Online brings together the academic strength of the University, and the publishing and assessment strengths of Cambridge University Press and Cambridge Assessment, allowing you to develop your skills and specialise in emerging areas that address global challenges.

Our certificated courses will reflect the Cambridge experience and values, with low student to tutor ratios and academically rigorous standards. They will allow you to engage directly with academics at Cambridge and are centred on rich interaction between

students and subject experts. Each course will offer you the opportunity to join live sessions with academics and interact in collaborative exercises with learners worldwide.

The University of Cambridge is committed to supporting lifelong learning and, through Cambridge Advance Online, has invested in the latest education technology to provide professionals with the very best experience wherever they are in the world and at any stage of their career.

We look forward to welcoming you onto one of our courses and to our global community of learners.

Why Cambridge Advance Online?

Professor Graham Virgo

Senior Pro-Vice-Chancellor (Education)

(4)

04

Climate change and the pandemic are leading to a fundamental rethink about ourselves, our society and the world we live in. These challenges demand new thinking from universities, researchers and students, who are perfectly poised to make major contribution to solving these problems as demonstrated by innovative solutions universities have delivered during the COVID crisis.

This recognition of the critical and integral role that universities and research play within the innovation ecosystem poses the question of how technology transfer professionals can effectively support knowledge exchange and research commercialisation to create benefit for both the economy and humankind.

At Cambridge Enterprise, we strive to bring novel insights and innovations into the world. We are also passionate about using our learning and experience to support others around the globe to recognise, harness and create impact from the research within their universities, research centres and institutions. In designing this course, we have drawn on 50 years of experience in research commercialisation and will share with you an extensive understanding of technology transfer, alongside how Cambridge Enterprise works, its values, and our approach. This course is not designed as a playbook but as an individual exploration of how you can create impact within your own context.

We hope that this course gives you the tools and inspiration that you need to deliver further benefits from your institution to society, support local development, and position your institution in the local innovation community. This course will also create you a network of like-minded professionals that you can engage with and learn from – throughout the course and in the future.

Dr. Paul J Seabright

Deputy Director, Cambridge Enterprise

Welcome to Research

Commercialisation and

Technology Transfer

(5)

Timetable:

September | January | April | June

Subject area:

Enterprise and Knowledge Transfer

Format and length:

8 weeks | 8-10 hours per week

Price:

£2,200

This course gives you the tools to turn academic research into commercial ventures that will generate societal impact around the world. Using case studies from Cambridge Enterprise, one of the world’s most successful technology transfer offices, you will be given a broad overview by leading practitioners with direct experience in the field.

You will examine key topics including structuring your technology transfer office, intellectual property strategies and policies, consultancy, licensing and business creation as mechanisms for commercialisation, spin outs and seed funding, developing your negotiation skills, and creating engagement and evaluating impact.

On completion of the course, you will have a unique opportunity to purchase a series of additional mentoring sessions for up to 12 months. This involves working one on one with an experienced coach to further apply your learning and to support the successfully delivery of your action plan. Please contact [email protected] for more information.

Course Summary

05

ENTERPRISE & KNOWLEDGE TRANSFER

(6)

06

Is this course right for you?

This course will be of interest to:

– early- to mid-career professionals working in technology transfer – academics looking to maximise

the impact of their research – stakeholders who engage with

university technology transfer as part of their role

By the end of the course, you will be able to:

– evaluate how national and university level intellectual property and technology transfer contexts shape your activity

– evaluate, select and implement the most appropriate technology transfer mechanism and justify your decision

– evaluate and implement processes to manage TT mechanisms in your context – develop a toolkit to communicate with and

engage internal and external stakeholders

What you will learn

on the course?

(7)

Module 0 Module 2 Module 4 Module 1 Module 3

Impact through innovation (weeks 1)

– Describe the contribution of a technology transfer office in creating impact from research – Define the role of universities

as a key driver for the development and success of Innovation Ecosystems

The bright idea and what to do with it (week 3)

– Conduct an initial evaluation of a variety of disclosures – Develop a process to evaluate

early-stage technology opportunities.

– Compare exploitation mechanisms and select the most appropriate one for your context.

It’s not what you know, it’s who you know (week 8)

– Create engagement strategies for internal and external stakeholders

Understanding the basics (weeks 2)

– Analyse the options for the structure of Technology Transfer Offices, and how to measure success

– Assess the challenges and opportunities for different approaches to intellectual property protection and exploitation.

Making it happen (weeks 4-7)

– Evaluate the potential of research collaborations to drive university impact in your context.

– Create a Consultancy process for your context

– Create a licensing process for your context

– Create support and funding mechanisms for University spin outs in your context

– Negotiate with third parties to gain a fair and equitable agreement

Key learning objectives

07

ENTERPRISE & KNOWLEDGE TRANSFER

(8)

08

The learning journey

Orientation

You will get access to familiarise yourself with our learning platform, Canvas, start networking with peers and hear from your course leader.

Week 1 Week 2 Week 3

Cambridge Advance Online courses are delivered over 6 to 8

consecutive weeks (dependent on the programme), with each week’s

content following a clear, deliverable path to help facilitate learning.

(9)

Week 4 Week 5 Week 6 Week 7*

Week 8*

Join our

Alumni network

09

ENTERPRISE AND KNOWLEDGE TRANSFER

*The duration of the programme is dependent on the course. Please check the course summary for information regarding course length.

(10)

10

Learning

breakdown

Built content

(e.g. videos, animations, quizzes)

Discussion

1 hr 1 .5 hrs 4 hrs

Our online courses combine several different elements to create a balanced blend of learning. Participants will be able to learn at their own pace during the week, viewing content, engaging in discussions and completing any assignments. On average, our courses take 8 to 10 hours per week.

1 .5 hrs

(11)

11

ENTERPRISE & KNOWLEDGE TRANSFER

Paul is responsible for implementing a five year strategy that aims to enhance our customer service so that we can help more academics, researchers, companies and investors to create a positive impact on society.

A cornerstone of the strategy is the introduction of a new IT system that will enable customers to access data as well as driving greater efficiency within the business.

Paul was previously Head of Consultancy Services for six years, during which period he doubled the team’s turnover. He is a Board member and Director of three University of Cambridge subsidiary companies: Cambridge Enterprise Limited, Cambridge University Technical Services (CUTS) Limited and Institute for Manufacturing Education and Consultancy Services Limited.

Paul has considerable experience of technology transfer in both the biotech and medtech sectors.

He was previously Head of Business Development at Health Enterprise East, where he was instrumental in building a successful technology transfer and consultancy organisation for the NHS.

Paul has a degree in Biochemistry and a PhD in Chemistry from Manchester. After his PhD, he became a post-doctoral researcher for the Medical Research Council and then later for the University of Cambridge.

Consultancy Services is a fast-growing service dedicated to generating both societal and economic impact from academic research by facilitating consultancy between University academics from across all disciplines within the University and external organisations.

The Consultancy Services team has supported almost 400 consultancy projects this past year of which many arose from Arts, Humanities or Social Science disciplines. In 2017-18, Amanda’s team saw a 63% increase in the number of new consultants with deals signed for 165 academics and 234 clients in that period.

Amanda periodically delivers training to technology transfer professionals for PraxisAuril, the

Association of University Technology Managers (AUTM) and the European Association for Technology Transfer Professionals (ASTP), and is on the Board of Directors for ASTP as VP for Professional Development.

Meet your tutors

Dr Paul Seabright

Deputy Director of Cambridge Enterprise

Dr Amanda Zeffman

Head of Consultancy Services

(12)

12

Iain is responsible for a team that is working across the life sciences sector from human health therapeutics to agritech and research tools. Iain has a PhD in Organic Chemistry (Sydney) and MBA (Cambridge).

The team has spun-out companies including X01 Therapeutics, Apcintex (now a Centessa company), DIOSynVax, NoBACZ Healthcare, Predictimmune Limited, PhoreMost, Z-factor and Cambridge Epigenetix. Iain, with colleagues from partner universities founded Apollo Therapeutics, a

£40 million fund in early stage drug development and launched the Ceres Agritech Knowledge Exchange Partnership. Iain also led discussions with GSK in respect of the University of Cambridge-GSK open innovation drug discovery initiative based at the Stevenage Bioscience Catalyst.

Marcio works to help researchers commercialise technologies from across the whole range of the Schools of Physical Sciences and Technology.

Prior to joining Cambridge Enterprise, Marcio was with Imperial College London in a similar role for close to two years. Before that, Marcio enjoyed working in his own company in the field of scientific instrumentation for high pressure research, from where he exited in 2018, after 16 years. At the time of his exit the company had offices in the UK, US, Belgium and China.

Previous to this, he worked for a medical devices company with full new product development and introduction responsibilities.

His scientific background is in physics, with a PhD from Royal Holloway, University of London. He also has an MBA from the University of Surrey and is a Certified Licensing Professional.

Dr Iain Thomas

Head of Life Sciences at Cambridge Enterprise

Dr Marcio Siqueira

Head of Physical Sciences

(13)

13

ENTERPRISE & KNOWLEDGE TRANSFER

Christine has a focus on drug discovery with a broad portfolio of technologies, including University of Cambridge spin-outs Carrick, STORM, Z-factor, PhoreMost, Qkine and PolyProX. Christine was featured in BioBeat’s 50 Movers and Shakers in BioBusiness 2018.

Previously, Christine worked for six years in the Life Sciences Tech Transfer team managing licensing of University IP, including licences to Cambridge spin-outs Carrick, Storm and CEGX and managing the formation of the spin-out Z-factor. Christine also managed the University of Cambridge-GSK open innovation drug discovery initiative based at the SBC, working closely with academics to gain funding to develop translational projects.

Christine has an MA and DPhil from the University of Oxford. She is the author of over 20 peer reviewed journal articles and over 20 patents. She was also the recipient of the Arthur E. Schwarting award for the best article published in the Journal of Natural Products in 2006.

As Head of Seed Funds at Cambridge Enterprise, Anne has overseen strong growth in our

investment activities, with Seed Funds investing over £5 million each year in young companies.

Recent highlights include the purchase of Cambridge CMOS Sensors by ams, and the sale of Quethera to Astellas Pharma. Anne has also served on many boards including those of Cambridge CMOS Sensors, Aqdot, Cambridge Touch Technologies, Psyomics, MorphoenIX and Quethera. She was a founding member of Praxis Auril, which supports Knowledge Exchange Commercialisation in the UK.

Anne joined the technology transfer team at the University of Cambridge in 2001, and has been involved with Cambridge Enterprise since its foundation in 2006, including as Interim Director just prior to this. She joined the Seed Funds team in 2008 and was appointed Head of Seed Funds in 2011.

Dr Christine Martin

Head of Life Science investment

Dr Anne Dobrée

Head of Seed Funds

(14)

14

Technical requirements

– Sufficient internet speed and stability for video streaming (2 Mbps up/down)

– No specialist software required – Please see our recommendations

on web browsers:

https://bit.ly/2S4Qhh4

Course certification

You’ll be assessed using a range of modalities that emphasize real- world application of course material.

On completion of your Cambridge Advance Online course, you will be eligible for a Certificate of Achievement and digital badge.

To get your Certificate you must achieve a minimum grade of 70%

on course activities and your final tutor-marked project.

(15)
(16)

References

Related documents

Methods that allow for such dynamic software replacement and their application to network management are the object of this research.. Cercio and Pelaggi [2] outline the problem

Katie Kaczmarski is currently a PGY2 Ambulatory Care Specialty Resident with Veterans Affairs North Texas Health Care System and Texas Tech University Health Science Center School

Stem cell research enjoyed a breakthrough when, in 2006, Japanese researcher Shinya Yamanaka, a professor at the Institute for Frontier Medical Sciences at Kyoto University and at

The aim of our study was to compare toxicities, response rates and survival outcomes in patients with HIV-associated lymphoma treated with chemotherapy according to whether

organisational models, and so the organisational costs were relatively small. The former Soviet farms could easily be restructured into production co-operatives with most of the

• Built on the medium duty engine project that was part of the UD Trucks acquisition • MDE 5, MDE 7, MDE 8 • Automotive and industrial • PNLT, EPA 2010, Euro III-VI,.

Speaker, "The Generation-Skipping Transfer Tax - Current Problems and Developments," 27th Southern California Tax and Estate Planning Forum and 33rd Annual Notre Dame Tax

• Income Benefit - Income Benefit equal to 10% of the • Income Benefit - Income Benefit equal to 10% of the Basic Sum Assured is payable on each Policy anniversary from the